Attention-deficit/hyperactivity disorder is one of the most extensively studied conditions in child psychiatry, yet it remains one of the most misunderstood. Parents arrive at clinical evaluations having absorbed years of contradictory messages: that ADHD is overdiagnosed, that it is caused by poor parenting or too much screen time, that medication is overprescribed, or that children will simply grow out of it. The evidence tells a different story — one of a highly heritable neurodevelopmental condition with significant consequences when untreated and substantial benefits when properly managed.
Drawing on Lewis’s Child and Adolescent Psychiatry and current clinical guidelines, this article provides an evidence-based overview for parents and clinicians.
What ADHD Actually Is
ADHD is a neurodevelopmental disorder characterized by persistent and impairing symptoms of inattention, hyperactivity, and impulsivity that are inconsistent with the child’s developmental level. Twin studies consistently show heritability estimates of approximately 70 to 80 percent, comparable to height. Neuroimaging research has identified structural and functional differences in prefrontal regions responsible for executive functions including working memory, inhibitory control, and attention regulation. These differences are not the result of parenting, diet, or screen time. They are part of the neurobiology of the condition.
Research consensus: ADHD has one of the strongest genetic contributions of any psychiatric disorder, with heritability estimates of 70-80%. The condition is not caused by parenting, screen time, or diet, though environmental factors can influence severity and presentation.
How ADHD Presents Across Development
In preschool children, ADHD presents as extreme motor activity — climbing, running, exploring constantly — well beyond same-age peers. In school-age children, inattention becomes more evident as academic demands increase. The child may be unable to complete assignments without constant redirection, lose materials repeatedly, and avoid tasks requiring sustained mental effort. In adolescents, hyperactivity often diminishes externally but persists as internal restlessness. Inattention and disorganization become the primary impairments, and the risk of academic failure, social difficulties, and risky behaviors peaks during this period.
Evidence-Based Treatment
Treatment involves a multimodal approach. Behavioral interventions include parent training and classroom-based strategies. Stimulant medications — methylphenidate and amphetamine formulations — show the largest effect sizes and work by increasing dopamine and norepinephrine availability in prefrontal circuits. Non-stimulant options including atomoxetine and guanfacine are alternatives when stimulants are ineffective or contraindicated.
The decision to treat should be weighed against the risks of untreated ADHD, which include higher rates of academic failure, peer rejection, accidental injuries, substance use disorders, and occupational instability. These outcomes are risks that evidence-based treatment demonstrably reduces.
When to Seek Evaluation
- Symptoms have been present for at least six months and clearly exceed developmental norms
- Symptoms cause significant impairment across at least two settings — typically home and school
- Academic performance is declining despite adequate cognitive ability
- Peer relationships are consistently affected by impulsivity, inattention, or emotional dysregulation
- The mismatch between the child’s apparent capability and their actual functioning is significant and sustained
Conclusion
ADHD is real, neurobiological, and highly treatable. The most important step is accurate assessment followed by evidence-based intervention. Treatment does not change who a child is. It removes the barriers that prevent a child from functioning as they are capable of functioning — at school, with peers, and within their family.
